Chronic Migraine Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
Chronic migraine is headache occurring on 15 or more days per month for more than three months, which, on at least 8 days per month, has the features of migraine headache. Chronic migraine occurs in approximately 1% of the population.
MARKET DYNAMICS
The chronic migraine treatment market is anticipated to grow in the forecast period due increase in female population and surge in awareness among patients related to prevention and treatment of migraine. However, side effects associated with migraine drugs is a factor is restraining the market growth. Moreover, the presence of growth opportunities in emerging nations is expected to provide new opportunities for the key players in the forecast period.
MARKET SCOPE
The "Chronic Migraine Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in chronic migraine treatment market with detailed market segmentation by treatment, route of administration, distribution channel and geography. The chronic migraine treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in chronic migraine treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The chronic migraine treatment market is segmented on the basis of treatment, route of administration and distribution channel. Based on type the market is segmented as abortive treatment and prophylactic treatment. Further on the basis of abortive treatment the market is categorized as triptans, ergot alkaloids and others. Further on the basis of prophylactic treatment the market is categorized as botulinum toxin, topiramate and others. On the basis of route of administration the market is categorized as oral, injectable and others (nasal spray, transdermal patch, suppositories). On the basis of distribution channel the market is categorized as hospitals pharmacies, retail pharmacies and others (online pharmacies, drug stores).
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in chronic migraine treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The chronic migraine treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting chronic migraine treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the chronic migraine treatment market in these regions.
By Treatment
By Route of Administration
By Distribution Channel [Hospitals Pharmacies, Retail Pharmacies, Others
MARKET PLAYERS
The report covers key developments in the in chronic migraine treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in chronic migraine treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for in chronic migraine treatment market in the global market. Below mentioned is the list of few companies engaged in the chronic migraine treatment market.
The report also includes the profiles of key in chronic migraine treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Alder BioPharmaceutical, Inc.
- Allergan plc.
- AstraZeneca plc.
- Eisai Co., Ltd.
- Eli Lilly & Company
- Endo Pharmaceutical Inc.,
- GlaxoSmithKline plc.
- Janssen Pharmaceutical Company (Johnson & Johnson)
- Merck & Co., Inc.
- Zosano Pharma Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Chronic migraine is headache occurring on 15 or more days per month for more than three months, which, on at least 8 days per month, has the features of migraine headache. Chronic migraine occurs in approximately 1% of the population.
MARKET DYNAMICS
The chronic migraine treatment market is anticipated to grow in the forecast period due increase in female population and surge in awareness among patients related to prevention and treatment of migraine. However, side effects associated with migraine drugs is a factor is restraining the market growth. Moreover, the presence of growth opportunities in emerging nations is expected to provide new opportunities for the key players in the forecast period.
MARKET SCOPE
The "Chronic Migraine Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in chronic migraine treatment market with detailed market segmentation by treatment, route of administration, distribution channel and geography. The chronic migraine treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in chronic migraine treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The chronic migraine treatment market is segmented on the basis of treatment, route of administration and distribution channel. Based on type the market is segmented as abortive treatment and prophylactic treatment. Further on the basis of abortive treatment the market is categorized as triptans, ergot alkaloids and others. Further on the basis of prophylactic treatment the market is categorized as botulinum toxin, topiramate and others. On the basis of route of administration the market is categorized as oral, injectable and others (nasal spray, transdermal patch, suppositories). On the basis of distribution channel the market is categorized as hospitals pharmacies, retail pharmacies and others (online pharmacies, drug stores).
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in chronic migraine treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The chronic migraine treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting chronic migraine treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the chronic migraine treatment market in these regions.
Chronic Migraine Treatment Market Report Analysis
Chronic Migraine Treatment Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Alder BioPharmaceutical, Inc.
- Allergan plc.
- AstraZeneca plc.
- Eisai Co., Ltd.
- Eli Lilly and Company
- Endo Pharmaceutical Inc.,
- GlaxoSmithKline plc.
- Janssen Pharmaceutical Company (Johnson and Johnson)
- Merck and Co., Inc.
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Treatment
- Abortive Treatment
- Prophylactic Treatment
By Route of Administration
- Oral
- Injectable
- Others
By Distribution Channel [Hospitals Pharmacies, Retail Pharmacies, Others
- Online Pharmacies
- Drug Stores]
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the in chronic migraine treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in chronic migraine treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for in chronic migraine treatment market in the global market. Below mentioned is the list of few companies engaged in the chronic migraine treatment market.
The report also includes the profiles of key in chronic migraine treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Alder BioPharmaceutical, Inc.
- Allergan plc.
- AstraZeneca plc.
- Eisai Co., Ltd.
- Eli Lilly & Company
- Endo Pharmaceutical Inc.,
- GlaxoSmithKline plc.
- Janssen Pharmaceutical Company (Johnson & Johnson)
- Merck & Co., Inc.
- Zosano Pharma Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Chronic Migraine Treatment Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Treatment
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Alder BioPharmaceutical, Inc.
2. Allergan plc.
3. AstraZeneca plc.
4. Eisai Co., Ltd.
5. Eli Lilly and Company
6. Endo Pharmaceutical Inc.,
7. GlaxoSmithKline plc.
8. Janssen Pharmaceutical Company (Johnson and Johnson)
9. Merck and Co., Inc.
10. Zosano Pharma Corporation
1. Alder BioPharmaceutical, Inc.
2. Allergan plc.
3. AstraZeneca plc.
4. Eisai Co., Ltd.
5. Eli Lilly and Company
6. Endo Pharmaceutical Inc.,
7. GlaxoSmithKline plc.
8. Janssen Pharmaceutical Company (Johnson and Johnson)
9. Merck and Co., Inc.
10. Zosano Pharma Corporation
Get Free Sample For